Protocol De-Risking

Protocol De-Risking2017-10-10T12:24:58+00:00

Process – Risk – Management

The success of any clinical trial is defined in the planning phase. The clinical trial is a complex process, which incorporates a number of internal (e.g. safety, protocol compliance, financial) and external (e.g. political, cultural) risks. Each risk has its own importance for a company and therefore must be analyzed locally in the context where a clinical trial takes place.

The Risk Defense Strategy, which Cyntegrity creates for its customers, can be compared to a house around the primary research outcome:

In order to de-risk a protocol of a trial Cyntegrity offers the following services:

Before clinical trial:

  • Risk analysis of the clinical Protocol (evaluation how risky the protocol is)
  • Definition of “Design space”
  • Finding the suitable Key Risk Indicators (KRIs)
  • Elaboration of Risk Defense Strategy
  • Writing of Monitoring plan and Risk-based Monitoring (RBM) plan

During clinical trial:

  • Automatic monitoring of such risks as:
    • protocol violation,
    • protocol amendment,
    • technical defects of EDC Software,
    • fraud,
    • misconduct of devices,
    • wrong calibration,
    • poor patient recruiting
  • Adjustment of the risks’ weights
  • Configuration and development of the new KRIs

After Clinical Trial:

  • Risk Management Study Report
  • Retrospective analysis of a clinical trial
  • Summing up the “Lessons learned” from the risk management

Interested in learning more about Cyntegrity and our services?

Contact Us

 

Upcoming Events

There are no upcoming events at this time.

Register Today!

Get Free Test Access